Partnership to advance the development of Regenerative Medicine
6 May 2024
CCRM Australia and Bioplatforms Australia Join Forces to Advance Regenerative Medicine
CCRM Australia, a leading organisation in regenerative medicine, and Bioplatforms Australia have officially signed a Memorandum of Understanding (MOU) to embark on a collaborative journey that will bolster research and innovation in regenerative medicine across Australia.
Under the MOU, both organisations have inaugurated a jointly funded shared position dedicated to advancing the growth and development of CCRM Australia and the StemCore facility in Brisbane. This shared role will oversee activities that align with the objectives of all three organisations, including but not limited to research, development, and innovation in regenerative medicine.
CCRM Australia and BPA will actively explore additional collaboration avenues that may encompass joint research endeavours, knowledge exchange, and the development of further collaborative projects, ultimately driving innovation and excellence in regenerative medicine.
Silvio Tiziani, CEO of CCRM Australia, expressed his enthusiasm about the partnership, stating, "This collaboration with Bioplatforms Australia is another significant milestone for CCRM Australia. It reflects our shared commitment to advancing the sector and the mutual recognition that supporting and building the Australian regenerative medicine and advanced therapies ecosystem benefits all."
Andrew Gilbert, Chief Executive of Bioplatforms Australia, echoed these sentiments: "We are excited to partner with CCRM Australia. The national and international approach and connections that CCRM Australia brings as a member of an active CCRM Global Network is something that we feel contribute to us building a national commercialisation and impact through ecosystem development.”
About CCRM Australia:
CCRM Australia is an Australian not-for-profit organisation supporting the development of foundational technologies to accelerate the commercialisation of regenerative medicine products and therapies. CCRM Australia's focus is to bridge the commercialisation gap through a network of scientists, entrepreneurs, academic institutions and industry partners and address bottlenecks in the industry. CCRM Australia is modelled on the highly successful CCRM in Canada and is legally separate from CCRM. As a member of the Global CCRM network, CCRM Australia is a partner to a leading-edge industry consortium.
For more information, please contact Silvio Tiziani:
m: +61 (0)4 1853 6209
e: silvio.tiziani@ccrmaustralia.com.au
About Bioplatforms Australia:
Bioplatforms Australia is a non-profit organisation that empowers Australian life science research by investing in cutting-edge infrastructure and expertise across the ‘omics, Boinformatics and Synthetic Biology. Funded through the Commonwealth Government National Collaborative Research Infrastructure Strategy (NCRIS), Bioplatforms Australia enhances research capabilities, supports innovation, and translates scientific outcomes into tangible benefits for Australians.
For more information, please contact Andrew Gilbert:
m: +61 410 538 648
About Stemcore
StemCore enables Australian academics and clinicians to advance their research throughput by providing cost-effective human stem cell-related products and services. We specialise in a wide range of tasks, including providing quality-assured embryonic stem cells, reprogramming adult cells to induced pluripotent stem cells, and a diverse array of gene editing products for disease models and reporter lines.
For more information, please contact Andrew Prowse:
m: +61 733 463 485